Child Obesity Factors Can Lead to Increased Suicide Attempts

There are many child obesity factors that can lead to increased suicide attempts in obese children. Obesity in children leads to kids having to deal with hazing, depression, bullying and lower self esteem. Every day they get put down and demeaned because of their weight, they get picked last in gym, kids avoid playing with them, and they have trouble fitting in. When you combine all of these factors, you get a suicide attempt.

Some parents may think that suicide is nothing to worry about, since they are under the false impression that suicide is not a big threat and is just a rare occurrence. Well they'd be wrong. Suicide is a major threat in this country. Every year more than 300,000 kids aged 15 to 24 attempt suicide. And there are also another 17,000 suicide attempts made by kids aged 10 to 14.

To put that in terms easier to comprehend. The 300,000 kids in the 15 to 24 group who attempted suicide, would make up the undergraduate student bodies of about 12 universities. While the 17,000 kids in the 10 to 14 group, would make up the student bodies of about 15 middle schools. And children suffering from childhood obesity are at a higher risk of trying suicide than their peers.

However, before the kids decide to attempt killing themselves, they will almost always give you warning signs about their future attempt to gauge your reaction. In fact 75% will even give you a verbal warning about their intention. It will not be as clear as "mom I'm going to try killing myself tomorrow", but afterwards, after your child is dead or hospitalized, you'll be able to look back and find the 1-2 sentences which could have helped you save the child's life. Unfortunately most parents will ignore the warning signs, and will just brush them off as "kids will be kids", which is absolutely the worst thing you can do, since it gives the child the green light by giving them the idea that no one would miss them if they were gone.

Hopefully this child obesity article opened your eyes about the risk of suicide in obese children. If you have an obese child, it's your responsibility to learn all the potential suicide warning signs so that you'll be able to notice when you child becomes suicidal and can intervene to safe their live.

What is ataxia-telangiectasia? Rare genetic disorder causes loss of muscle control, failing immune system, increased cancer risk | Health, Medicine and Fitness

Ataxia-telangiectasia is a rare genetic, progressive degenerative disease that usually manifests in young children about the time they’re learning to walk and affects a wide range of systems within the body as the part of the brain called the cerebellum begins to degenerate.

Wobbling or swaying when toddlers walk, stand or sit is the most common initial system, according to the A-T Children’s Project, a nonprofit organization that supports biomedical research, scientific conferences and a clinical center searching for therapies to improve victims’ quality of life and, ultimately, a cure.

By the time they’re in preschool or kindergarten, children with the disease have trouble shifting their gaze normally, develop slurred or distorted speech and have difficulty swallowing, all the result of the “ataxia” portion of the disorder.

As it progresses, the disease causes their speech to become more slow and slurred and reading to become impossible. They also lose their ability to write, and most are confined to a wheelchair by the age of 10.

Soon after the ataxia symptoms start, victims develop the “telangiectasia” effects — tiny red “spider” veins that appear in the corners of the eyes and on the surfaces of the ears and nose when exposed to sunlight.

About 70 percent of those with A-T will also develop an immunodeficiency that leaves them vulnerable to lung infections that are resistant to antibiotics and can lead to life-threatening cases of pneumonia, according to the A-T Children’s Project.

Children with A-T also have an increased risk of cancer — up to 1,000 times greater than the general population has of developing blood malignancies. Lymphoma and leukemia are common among A-T patients, yet the disease also makes them more sensitive to radiation, so they can’t tolerate normal therapeutic levels that would be used to treat cancers.

Other problems often afflicting A-T patients include diabetes mellitus, slowed growth, choking and drooling because of the difficulty in swallowing and hair becoming prematurely gray.

Get tips on free stuff and fun ideas delivered weekly to your inbox

Despite their physical symptoms, their intellect is unaffected, and they are socially aware and skilled.

There is no cure for the disease, which the A-T Children’s Project calls “unrelenting,” and there is no way to slow its progression. The only thing doctors can do is alleviate some of the symptoms through physical and speech therapy, and injections of gamma globulin to support the immune system along with high doses of vitamins.

The disease itself is so rare — estimated at one in 40,000 to 100,000 births — it’s called an “orphan” disease. Few people know of it, data on beneficial pharmaceuticals are extremely scarce and the funds available for research into potential cures and therapies are a fraction of those available for high-profile diseases.

For more information about ataxia-telangiectasia, visit the A-T Children’s Project website at www.atcp.org.

What is ataxia-telangiectasia? Rare genetic disorder causes loss of muscle control, failing immune system, increased cancer risk | Health & Fitness

Ataxia-telangiectasia is a rare genetic, progressive degenerative disease that usually manifests in young children about the time they’re learning to walk and affects a wide range of systems within the body as the part of the brain called the cerebellum begins to degenerate.

Wobbling or swaying when toddlers walk, stand or sit is the most common initial system, according to the A-T Children’s Project, a nonprofit organization that supports biomedical research, scientific conferences and a clinical center searching for therapies to improve victims’ quality of life and, ultimately, a cure.

By the time they’re in preschool or kindergarten, children with the disease have trouble shifting their gaze normally, develop slurred or distorted speech and have difficulty swallowing, all the result of the “ataxia” portion of the disorder.

As it progresses, the disease causes their speech to become more slow and slurred and reading to become impossible. They also lose their ability to write, and most are confined to a wheelchair by the age of 10.

Soon after the ataxia symptoms start, victims develop the “telangiectasia” effects — tiny red “spider” veins that appear in the corners of the eyes and on the surfaces of the ears and nose when exposed to sunlight.

About 70 percent of those with A-T will also develop an immunodeficiency that leaves them vulnerable to lung infections that are resistant to antibiotics and can lead to life-threatening cases of pneumonia, according to the A-T Children’s Project.

Children with A-T also have an increased risk of cancer — up to 1,000 times greater than the general population has of developing blood malignancies. Lymphoma and leukemia are common among A-T patients, yet the disease also makes them more sensitive to radiation, so they can’t tolerate normal therapeutic levels that would be used to treat cancers.

Other problems often afflicting A-T patients include diabetes mellitus, slowed growth, choking and drooling because of the difficulty in swallowing and hair becoming prematurely gray.

Get tips on free stuff and fun ideas delivered weekly to your inbox

Despite their physical symptoms, their intellect is unaffected, and they are socially aware and skilled.

There is no cure for the disease, which the A-T Children’s Project calls “unrelenting,” and there is no way to slow its progression. The only thing doctors can do is alleviate some of the symptoms through physical and speech therapy, and injections of gamma globulin to support the immune system along with high doses of vitamins.

The disease itself is so rare — estimated at one in 40,000 to 100,000 births — it’s called an “orphan” disease. Few people know of it, data on beneficial pharmaceuticals are extremely scarce and the funds available for research into potential cures and therapies are a fraction of those available for high-profile diseases.

For more information about ataxia-telangiectasia, visit the A-T Children’s Project website at www.atcp.org.

UnitedHealth Group Incorporated (NYSE:UNH) Trading Up – Short Interest increased by 7.73%

Advertisement

Investors are a little more bearish on the company at least if you consider the motion in short interest. The firm saw a rise in short interest of 7.73% between July 31, 2017 and August 15, 2017. Short interest grew from 9,598,808 to 10,340,622 over that timeframe. Days to cover increased from 0.0 to 4.0 and the percentage of shorted shares was 0.01% on August 15.

Here are a few substantial investment firms who have updated their positions. Cantab Capital Partners Llp added to its ownership by buying 3,510 shares an increase of 24.8% from 03/31/2017 to 06/30/2017. Cantab Capital Partners Llp claims 17,650 shares valued at $3,273,000,000. The total value of its holdings increased 141,038.4%. Gwm Advisors LLC augmented its position by buying 2,199 shares an increase of 47.6% as of 06/30/2017. Gwm Advisors LLC currently owns 6,823 shares with a value of $1,275,500,000. The value of the position overall is up by 167,069.1%.

As of quarter end Koshinski Asset Management, Inc. had acquired a total of 1,738 shares growing its holdings by 34.3%. The value of the investment in UNH increased from $829,000 to $1,260,711,000 a change of 151,976.1% quarter to quarter. Next Financial Group, Inc cut its stake by selling 99 shares a decrease of 3.8%. Next Financial Group, Inc now holds 2,513 shares worth $466,000,000. The total value of its holdings increased 101,869.4%.

August 17 investment analysts at Morgan Stanley left the stock rating at “Overweight” but moved up the price target from $202.00 to $215.00. On July 19 Citigroup held the company rating at “Buy” but raised the price target to $213.00 from $164.00.

On July 19 Barclays kept the stock rating at “Overweight” but raised the price expectation from $164.00 to $217.00. July 14 investment analysts at Bank of America maintained a company rating of “Buy” and raised the price expectation from $112.00 to $197.00.

On July 13 Deutsche Bank made no change to the company rating of “Buy” and raised the price target to $197.00 from $127.00.

The company is now up by 0.903% percent from yesterday’s close. UnitedHealth Group Incorporated declared a dividend for shareholders to be paid on Tuesday the 19th of September 2017. The dividend payment will be $0.750 per share for the quarter which comes to $3.00 on an annualized basis. This dividend amount will represent a yeild of $1.51. The ex-dividend date will be on Thursday the 15th of June 2017.

It is currently trading at $199.42 which is just over the 50 day moving average of $193.75 and which is significantly higher than the 200 day moving average of $179.09. The 50 day moving average was up $5.67 or +2.927% whereas the 200 day average was up by +11.347%.

The company currently has a P/E ratio of 23.957 and the market cap of the company is 192.81B. In the latest earnings report the EPS was $8.32 and is expected to be $9.87 for the current year with 966,859,000 shares presently outstanding. Next quarter’s EPS is estimated at $2.49 and the next full year EPS is projected to be $10.85.

UnitedHealth Group Incorporated, launched on July 1, 2015, is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum. UnitedHealthcare provides healthcare benefits to an array of customers and markets, and includes UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State, and UnitedHealthcare Global businesses. Optum is a health services business serving the healthcare marketplace, including payers, care providers, employers, governments, life sciences companies and consumers, through its OptumHealth, OptumInsight and OptumRx businesses..

UnitedHealth Group Inc (UNH) Seeing Increased Volatility in Session

Shares of UnitedHealth Group Inc (UNH) are moving on volatility today 0.25% or 0.50 from the open. The NYSE listed company saw a recent bid of 198.13 and 408345 shares have traded hands in the session.

Investors are always looking to gain any possible advantage in the stock market. Knowing the various risk and return possibilities for various types of stocks can be critical to positive performance. Creating a balanced equity portfolio may be the essential first step when thinking about diving into the equity markets. Investors may come from all different types of backgrounds, and they may face completely different situations. Each investor may need to identify their objectives and try to figure out what’s best for their specific situation. Investors may want to take a conservative approach to the markets. Others will be looking to go in full throttle with a very aggressive plan. Whatever the choice, it is important to note that picking stocks based on previous returns will never guarantee future returns. Investors have many choices they can make when looking to purchase stocks. Figuring out levels of risk, expectations of returns, and the overall investment time horizon can all play a big part in crafting the initial plan.

Now let’s take a look at how the fundamentals are stacking up for UnitedHealth Group Inc (UNH). Fundamental analysis takes into consideration market, industry and stock conditions to help determine if the shares are correctly valued. UnitedHealth Group Inc currently has a yearly EPS of 8.32. This number is derived from the total net income divided by shares outstanding. In other words, EPS reveals how profitable a company is on a share owner basis.

Another ratio we can look at is the Return on Invested Capital or more commonly referred to as ROIC. UnitedHealth Group Inc (UNH) has a current ROIC of 11.38. ROIC is calculated by dividing Net Income – Dividends by Total Capital Invested.

Similar to ROE, ROIC measures how effectively company management is using invested capital to generate company income. A high ROIC number typically reflects positively on company management while a low number typically reflects the opposite.

Turning to Return on Assets or ROA, UnitedHealth Group Inc (UNH) has a current ROA of 6.38. This is a profitability ratio that measures net income generated from total company assets during a given period. This ratio reveals how quick a company can turn it’s assets into profits. In other words, the ratio provides insight into the profitability of a firm’s assets. The ratio is calculated by dividing total net income by the average total assets. A higher ROA compared to peers in the same industry, would suggest that company management is able to effectively generate profits from their assets. Similar to the other ratios, a lower number might raise red flags about management’s ability when compared to other companies in a similar sector.

Figuring out when to sell a stock can be just as important as deciding what stocks to buy at the outset. Some investors may refuse to sell based on various factors. Investors may have become stubborn, too emotionally attached, or set too high of an expectation for a stock. Holding on to a stock for way too long in order to squeeze every last drop of profit out of a price move may leave the investor desperately searching for answers in the future. Investors may have different checklists for when it is time to sell a stock. Of course this depends largely on the individual and how much is at risk. Often times, investors will make a move to sell when the fundamentals drastically change, the dividend is cut, or a previous set target price has been hit. Getting out of a position at the right time is obviously not easy, but it may become a bit easier with time and research.

Another key indicator that can help investors determine if a stock might be a quality investment is the Return on Equity or ROE. UnitedHealth Group Inc (UNH) currently has Return on Equity of 20.39. ROE is a ratio that measures profits generated from the investments received from shareholders. In other words, the ratio reveals how effective the firm is at turning shareholder investment into company profits. A company with high ROE typically reflects well on management and how well a company is run at a high level. A firm with a lower ROE might encourage potential investors to dig further to see why profits aren’t being generated from shareholder money.